Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon I M
Laboratory of Molecular Cardiology, St. Boniface General Hospital Research Centre, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
J Mol Cell Cardiol. 1999 Mar;31(3):667-78. doi: 10.1006/jmcc.1998.0902.
We have previously shown that non-myocytes present in healed 8-week infarct scar overexpress transduction proteins required for initiating the elevated deposition of structural matrix proteins in this tissue. Other work suggests that TGF-beta 1 may be involved in cardiac fibrosis and myocyte hypertrophy. However, the significance of the altered TGF-beta signaling in heart failure in the chronic phase of post-myocardial infarction (MI), particularly in the ongoing remodeling of the infarct scar, remains unexplored. Patterns of cardiac TGF beta 1 and Smad 2, 3, and 4 protein expression were investigated 8 weeks after MI and were compared to relative collagen deposition in border tissues (containing remnent myocytes) and the infarct scar (non-myocytes). Both TGF-beta 1 mRNA abundance and protein levels were significantly increased in the infarct scar v control values, and this trend was positively correlated to increased collagen type I expression. Cardiac Smad 2, 3, and 4 proteins were significantly increased in border and scar tissues v control values. Immunofluorescent studies indicated that Smad proteins localized proximal to the cellular nuclei present in the infarct scar. Decorin mRNA abundance was elevated in border and infarct scar, and the pattern of decorin immunostaining was markedly altered in remote remnant heart and scar v staining patterns of control sections. Expression of T beta RI (53 kDa) protein was significantly reduced in the scar, while the 75 kDa and 110 kDa isoforms of T beta RII were unchanged and significantly increased in scar, respectively. These results indicate that TGF-beta/Smad signaling may be involved in the remodeling of the infarct scar after the completion of wound healing per se, via ongoing stimulation of matrix deposition.
我们之前已经表明,存在于愈合8周的梗死瘢痕中的非心肌细胞会过度表达启动该组织中结构基质蛋白沉积增加所需的转导蛋白。其他研究表明,转化生长因子-β1(TGF-β1)可能参与心脏纤维化和心肌细胞肥大。然而,TGF-β信号改变在心肌梗死后(MI)慢性期心力衰竭中的意义,尤其是在梗死瘢痕的持续重塑中,仍未得到探索。在MI后8周研究了心脏TGF-β1以及Smad 2、3和4蛋白的表达模式,并将其与边缘组织(含有残余心肌细胞)和梗死瘢痕(非心肌细胞)中的相对胶原沉积进行比较。梗死瘢痕中的TGF-β1 mRNA丰度和蛋白水平均显著高于对照值,且这一趋势与I型胶原表达增加呈正相关。边缘组织和瘢痕组织中的心脏Smad 2、3和4蛋白显著高于对照值。免疫荧光研究表明,Smad蛋白定位于梗死瘢痕中细胞核附近。核心蛋白聚糖mRNA丰度在边缘组织和梗死瘢痕中升高,并且在远离的残余心脏和瘢痕中,核心蛋白聚糖免疫染色模式与对照切片的染色模式相比明显改变。瘢痕中TβRI(53 kDa)蛋白的表达显著降低,而TβRII的75 kDa和110 kDa异构体分别在瘢痕中无变化和显著增加。这些结果表明,TGF-β/Smad信号可能通过持续刺激基质沉积,在伤口愈合本身完成后参与梗死瘢痕的重塑。